China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.195
+0.015 (8.34%)
Dec 24, 2024, 11:08 AM EST - Market open
China Pharma Holdings Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 5.54 | 7.01 | 8.1 | 9.64 | 10.87 | 10.92 | Upgrade
|
| Revenue Growth (YoY) | -28.76% | -13.48% | -15.95% | -11.27% | -0.53% | -11.41% | Upgrade
|
| Cost of Revenue | 7.45 | 7.29 | 8.6 | 9.29 | 8.91 | 9.44 | Upgrade
|
| Gross Profit | -1.9 | -0.28 | -0.49 | 0.35 | 1.95 | 1.48 | Upgrade
|
| Selling, General & Admin | 2.23 | 2.25 | 2.96 | 3.15 | 4.04 | 4.64 | Upgrade
|
| Research & Development | 0.43 | 0.24 | 0.19 | 0.32 | 0.38 | 0.23 | Upgrade
|
| Operating Expenses | 2.67 | 2.47 | 3.06 | 3.21 | 4.53 | 4.87 | Upgrade
|
| Operating Income | -4.58 | -2.75 | -3.55 | -2.86 | -2.58 | -3.39 | Upgrade
|
| Interest Expense | -0.17 | -0.33 | -0.43 | -0.54 | -0.29 | -0.32 | Upgrade
|
| Interest & Investment Income | 0.01 | 0.01 | 0.01 | 0 | 0.01 | 0.03 | Upgrade
|
| EBT Excluding Unusual Items | -4.74 | -3.08 | -3.97 | -3.4 | -2.87 | -3.69 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -17.02 | Upgrade
|
| Pretax Income | -4.74 | -3.08 | -3.97 | -3.4 | -2.87 | -20.7 | Upgrade
|
| Net Income | -4.74 | -3.08 | -3.97 | -3.4 | -2.87 | -20.7 | Upgrade
|
| Net Income to Common | -4.74 | -3.08 | -3.97 | -3.4 | -2.87 | -20.7 | Upgrade
|
| Shares Outstanding (Basic) | 14 | 3 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 3 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 616.92% | 221.82% | 13.96% | 5.74% | 0.10% | - | Upgrade
|
| EPS (Basic) | -0.35 | -0.91 | -3.78 | -3.68 | -3.29 | -23.75 | Upgrade
|
| EPS (Diluted) | -0.35 | -0.91 | -3.78 | -3.68 | -3.29 | -23.75 | Upgrade
|
| Free Cash Flow | -0.75 | -0.71 | -0.81 | -0.69 | -0.91 | 0.47 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.21 | -0.77 | -0.75 | -1.04 | 0.54 | Upgrade
|
| Gross Margin | -34.34% | -4.01% | -6.09% | 3.62% | 17.97% | 13.57% | Upgrade
|
| Operating Margin | -82.55% | -39.25% | -43.79% | -29.67% | -23.73% | -31.06% | Upgrade
|
| Profit Margin | -85.56% | -43.91% | -49.02% | -35.26% | -26.38% | -189.51% | Upgrade
|
| Free Cash Flow Margin | -13.54% | -10.14% | -10.01% | -7.13% | -8.37% | 4.32% | Upgrade
|
| EBITDA | -1.71 | 0 | -0.85 | 0.23 | 0.1 | -0.46 | Upgrade
|
| EBITDA Margin | -30.87% | 0.03% | -10.47% | 2.36% | 0.93% | -4.25% | Upgrade
|
| D&A For EBITDA | 2.87 | 2.75 | 2.7 | 3.09 | 2.68 | 2.93 | Upgrade
|
| EBIT | -4.58 | -2.75 | -3.55 | -2.86 | -2.58 | -3.39 | Upgrade
|
| EBIT Margin | -82.55% | -39.25% | -43.79% | -29.67% | -23.73% | -31.06% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.